Papillary Thyroid Cancer and Central Lymp Node Dissection

Is Central Lymph Node Dissection Necessary in Suspected Papillary Thyroid Cancer and Papillary Thyroid Cancer?

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05873283

Enrollment

250

Registered

2023-05-24

Start date

2020-06-12

Completion date

2023-03-24

Last updated

2023-05-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Papillary Thyroid Cancer

Keywords

papillary thyroid cancer

Brief summary

Papillary cancer is a disease that spreads through lymphatic ways and its treatment is surgery. We performed prophylactic central dissection in addition to bilateral total thyroidectomy in patients with bethesda 5 and bethesda 6 biopsy results. We evaluated the pathology results retrospectively.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 85 Years

Healthy volunteers

Inclusion criteria

\- B5 and B6 biopsy results

Exclusion criteria

\- lobectomy

Design outcomes

Primary

Measure	Time frame	Description
Reaching 100 patients was the first target	18 months	100 patients

Countries

Turkey (Türkiye)

Outcome results